CSEM Endocrine Pearls Series
“From Gene to Clinic: Calcium‑Sensing Receptor Variants and Parathyroid Disease”
22 May, 12:15 – 12:45 PM
Online Section 1 Webinar
Section 1 Webinar
Friday, 22 May 2026
Learning Objectives
- Develop an approach to genetic forms of hypoparathyroidism
- Review the pathophysiology of calcium sensing receptor variants
- Describe novel approaches to therapy
Faculty
Ari Morgenthau
BSc., MSc., MD, FRCPC
(University of Toronto),
Moderator
Aliya Khan
MD, FRCPC, FACP, FACE
(McMaster University),
Speaker
The session is complimentary for CSEM members and $150 for non-members. If you would like to receive this education at the member rate, please login and renew.
This Group Learning activity (Section 1) was planned independently by CSEM to achieve scientific integrity, objectivity, and balance.
Sponsorship
Accreditation
Improving Consultation Notes for Endocrinology will be an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physicians and Surgeons of Canada, as approved by The Canadian Society of Endocrinology and Metabolism.
Registration
Ari Morgenthau BSc., MSc., MD, FRCPC
Dr. Ari Morgenthau is a Clinician-Teacher in the Division of Endocrinology and Metabolism, at the University of Toronto. Ari has a special interest in Endocrine Genetics and divides his clinical time between the Fred A. Litwin Family Centre in Genetic Medicine and the Toronto General Hospital General Endocrinology Clinic. Ari completed his MD at New York Medical College, his core Internal Medicine training at Dalhousie University, and his Adult Endocrinology and Metabolism training at the University of Toronto. Additionally, he completed a Clinical and Metabolic Genetics fellowship at the University of Toronto, has a Master of Science from the University of Calgary, and a Graduate Certificate in Genomic Counselling and Variant Interpretation from the University of British Columbia.
Conflict of Interest
Relationship – Global Genes, Non Financial Advisory Position related to the RARE Compassion Program.
Aliya Khan, MD, FRCPC, FACP, FACE
Aliya Khan is a Professor of Clinical Medicine at McMaster University, Director of the Calcium Disorders Clinic and the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors and completed postgraduate training at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease. She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. She was recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape.
Conflicts of Interest
Any direct financial payments including receipt of honoraria – Alexion, Amgen, Shire/Takeda, Ultragenyx, Chugai
Membership on advisory boards or speakers’ bureaus – Alexion, Amgen, Takeda, Ultragenyx, Chugai, Radius, Ascendis, Amolyt
Funded grants or clinical trials – Alexion, Amgen, Takeda, Ultragenyx, Chugai, Radius, Ascendis, Amolyt